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Communicable diseases are the major cause of 
mortality in lower-income countries. Two-thirds of 
the world’s HIV population live in sub-Saharan Africa 
(SSA) and 75% of global deaths due to this disease 
occur in this region.[1] As a result, both local and 
international resources have been channelled towards addressing the 
impact of communicable diseases. However, there is evidence that this 
pattern of disease burden in low-income countries (LICs) is changing, 
as HIV is being successfully treated and people are living longer.
Cancer predominantly affects the older population. As the life 
expectancy in LICs increases, the incidence of cancer will increase. 
The World Health Organization (WHO) has predicted a dramatic 
rise in the global number of cancer cases in the next 15 years, the 
majority of which will be in LICs and middle-income countries 
(MICs). It has been predicted that by 2020 there will be 17 million 
new cancer cases, and that by 2050 this figure will be 24 million. Of 
these cases, 70% will be in the developing world.[2]
The treatment of cancer is expensive and complex. In the USA, 
more than US$120 billion per year is spent on cancer care.[3,4] This is 
in stark contrast to the developing world, where 5% of global cancer 
funds are spent on 70% of the cancer cases (Table 1). 
In LICs, the delivery of healthcare is hampered by many 
socioeconomic factors such as poor nutrition, sanitation, literacy 
and transport, and is compounded by the lack of medical personnel, 
poor infrastructure and health policies.
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Table 1. Some discrepancies between LICs and HICs*[5]
LIC HIC
Life expectancy at birth (years) 57.8 82.4
Average GNI per capita
(2009, US$)
403 36 953
Total national health expenditure per capita
(2009, US$)
22 4 266
GDP spent on healthcare, % 5.1 11.2
Proportion of healthcare paid by public funding, % 42.0 61.3
Out-of-pocket health expenditure, % 79.2 36.3
LICs = low-income countries; HICs = high-income countries; GNI = gross national income; 
GDP = gross national product. 
* Figures based on World Bank Health, Nutrition and Population Statistics database.
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The sub-Saharan Africa 
perspective
According to the WHO, SSA comprises 
13% of the world’s population. It also carries 
24% of the global disease burden, but has 
only 1% of the global financial resources to 
do this. SSA’s demographics show a young 
population of whom 40% are <15 years of 
age. The mortality figures mirror this – 
80% of all deaths occur in those who are 
<60 years old. Conversely, in high-income 
countries (HICs), 80% of deaths occur in 
those >60 years of age.[6]
The cancer patterns seen in SSA are 
different from those in the developed world. 
Although the overall cancer incidence is 
lower than in developed countries, relatively 
more malignancies are seen in children and 
young people. The commonest malignancies 
in women are cervical and breast cancer.
There is a lack of medical personnel in 
SSA. The WHO recommends that ideally the 
physician:population ratio should be 50:100 000, 
while in Africa it is only 18:100 000. More than 
100 medical schools in SSA were surveyed; half 
of these reported losing 6 - 8% of their staff 
in the past 5 years.[7] 
While the management of cancer requires 
specialist knowledge, there is a paucity of all 
types of specialists in SSA. In addition, there 
are discrepancies within the SSA region, 
with South Africa (SA) faring better than its 
neighbours. In this regard, it should be noted 
that SA is essentially an MIC, but due to the 
gross disparities in socioeconomic class it 
is effectively both an HIC and a LIC. For 
example, in Uganda there are 10 specialist 
anaesthetists[8] compared with 800 in SA 
(I Buccimazza – unpublished data, 2008) 
(Fig. 1).
Not only are specialist resources 
scarce, but support services and essential 
medications are also lacking. Half of 
those who die from HIV need active pain 
management during the last 3 months of 
their life, while 80% of those who die from 
cancer need pain medication. Yet, access to 
oral morphine is available in fewer than 11 
African countries.[1]
Breast cancer in South 
Africa
The precise incidence of breast cancer in SA 
is unknown. There is no reliable national 
data registry, and the information available 
is gleaned from individual units in the 
larger healthcare centres. It is known that 
in state healthcare facilities, a significant 
number of patients present with clinically 
advanced disease. Treatment options are 
further compounded by a high incidence of 
HIV disease.
In a survey, the stage, HIV status and 
type of breast cancer in 1  200 women who 
presented to Chris Hani Baragwanath 
Academic Hospital were documented. Of 
those tested, 19.7% were HIV-positive, 
over half presented with locally advanced 
or metastatic cancer (stage 3 or 4) and 
1.5% presented with ductal carcinoma in 
situ (DCIS). In a screened UK population, 
nearly 20% of women were diagnosed with 
DCIS.[9,10]
The management guidelines formulated 
in HICs are unaffordable, unobtainable 
and inappropriate for the management 
of breast cancer in LICs. Sambo et al.[11] 
have summarised the challenges in cancer 
management in SSA as follows:
• Absence of cancer prevention, control
policy, strategies and programmes.
Most experts agree that mammographic
screening is unaffordable and breast
examination is generally not a good
screening modality. However, studies
have not tested this premise in countries
where most tumours are clinically obvious 
or advanced at presentation. A Sudanese
pilot study by Abuidris et al.[12] showed the
potentially beneficial effects of a cancer
awareness programme using trained non-
medical volunteers, and suggests that
clinical breast examination may be useful
in low-resource settings.[13] There is no 
national breast cancer policy in place, and
regional programmes are in their infancy.
A greater emphasis needs to be placed
on competent diagnostic units to fast
track patients with breast cancer to the
appropriate centre of care.
• Insufficient recent and comprehensive
data for cancer and death registration.
For any country to plan a comprehensive
health policy, a national register of disease 
incidence must be kept.
• The heavy economic and psychosocial
burden of cancer.
• Inadequate or no information about
cancer, insufficient numbers of skilled










Fig. 1. Comparison of the number of surgical specialists in South Africa (RSA) and Uganda.
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healthcare personnel, and scarce local, effective, and sustainable 
research. A number of initiatives are aimed at retaining medical 
personnel in their country of origin. The Medical Education 
Partnership Initiative (MEPI) 2010 provides funds to foreign 
institutions in SSA countries that receive US President’s Emergency 
Plan for AIDS Relief (US PEPFAR) support to develop or expand 
models of medical education. The aim is to improve the quality 
and quantity of graduates, retain specialists and improve research.[14] 
The African Organisation for Training and Research in Cancer 
(AORTIC) held a workshop in Durban to discuss ways of retaining 
specialists in their country of training.[15]
• The high cost of immunisation against human papillomavirus
and other infections that cause cancer. In SA, the state has
recently started a national human papillomavirus immunisation
campaign.
• Unavailability of secondary prevention for cancer amenable to
this intervention.
• Unaffordability of treatment resources and neglect of palliative
care. Oral morphine must be made available for use in palliative
care.
• Absence of collaboration or co-ordination of interventions
with regard to stakeholders and donors to combat cancer. It is
imperative that interested stakeholders unite and work towards a
common goal.
Conclusion
The incidence of breast cancer will increase significantly in all LICs. 
SA and its neighbouring countries will be significantly affected. It is 
therefore imperative that healthcare resources, policies and planning 
focus on this in a co-ordinated and rational way.
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